Clin2
NCT07294235Likely a fitRecruiting

Study of BGM1812 injection for healthy and overweight or obese participants

Overweight or Obesity

Part of Hormones & metabolism clinical trials.

This trial tests an investigational drug called BGM1812 given as an injection. It is for healthy Chinese adults who are either at a normal weight or are overweight/obese but not diabetic. The study will see how the drug works in the body and check for side effects.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 1
Enrollment
60 people
Ages
18 years to 55 years
Study type
Interventional

Who can take part

  • You are between 18 and 65 years old
  • You are either healthy with a BMI between 20 and 24, or overweight (BMI 24 to 28) or obese (BMI 28 or higher)
  • Your body weight has been stable (no big changes) for the past 12 weeks
  • You do not have diabetes
  • You agree to use effective birth control if needed, and not donate sperm for 3 months after the dose

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07224399Recruiting· Phase 1
Testing a new injection for weight loss in obesity

This trial tests a new injection (BGM1812) for weight loss in people who are overweight or obese. The injection is given under the skin, and the study will see how it works in your body and how safe it is.

Baltimore, Maryland
NCT06704581Recruiting· Phase 3
Study of BGM0504 injection for weight loss

This study tests a new weekly injection (BGM0504) to help people with obesity or overweight lose weight. It may be an option if you have not had success with diet and exercise alone and meet certain health criteria.

Beijing, Beijing Municipality
NCT07776041Not yet recruiting· Phase 1
Study of a new injection for healthy volunteers

This trial tests a new injection called SYH2092 in healthy adults, not for treating a disease. Participation helps researchers understand how the drug works in the body and if it is safe. If you qualify, you may be compensated for your time.

Melbourne, Victoria
NCT07239973Recruiting· Phase 1
Study of BGM0504 Tablets for overweight or obese adults

This trial tests a new tablet, BGM0504, in healthy adults who are overweight or obese but do not have diabetes. It aims to see how the medicine works and if it is safe for this group.

Kunming, Yunnan
NCT07779980Not yet recruiting· Phase 1
Study of an injection for weight management in healthy and overweight adults

This study tests a new injected medicine to see if it is safe and how it works in people who are overweight or obese, as well as in healthy volunteers. It may help with weight loss, but it is an early-phase trial to check safety first.

Kunming, Yunnan
NCT07382908Recruiting· Phase 1
Bioequivalence study of an injection for weight management

This trial tests if a new injection works the same as the approved version in overweight or obese adults. It may help if you are looking for a weight management treatment.

Hangzhou, Zhejiang

Hear when a new Overweight or Obesity trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.